The two human a-globin genes, al and a2 located 3.4 kilobases apart on chromosome 16 (Hb Hasharon), to the a2 locus. This approach could potentially be expanded to serve as an alternative to peptide analysis for the initial characterization of all globin structural mutants.
Introduction
Globin chain mutations are the best defined of all human protein defects. Due to the easy accessibility of red cells for analysis and the clinical presentation of many hemoglobinopathies, > 110 a-and 190 f3-globin structural mutants have now been identified (1) . A variety of techniques have been employed to assign a globin structural mutation to either the a or the i gene. These techniques are based upon alterations in the physical or chemical properties of the mutant globin protein.
Presently, the definitive assignment of a structural mutant as a or ,B (or less commonly y or 6) depends on the direct analysis of peptide fragments (2, 3) . Since the protein products of the two a-globin genes are normally indistinguishable (4) , it is not possible to similarly assign an a-globin structural Dr. Liebhaber is a fellow of the John A. and George L. Hartford Foundation.
Received for publication 3 July 1984 and in revised form 17 September 1984. mutant to its encoding gene on the sole basis of protein analysis. For this reason, a full genetic description of most aglobin structural mutations remains incomplete.
Despite the incomplete genetic description of most aglobin structural mutants, the level of a-globin protein present in individuals with a-globin structural mutations has been used to infer certain features of a-globin gene regulation. In most of these individuals, the a-globin mutation is present in one of the four a-globin genes, and is expressed at 25% of total a-globin (5) . This finding suggests that the four a-globin genes are equally expressed at the protein level. Levels of aglobin mutant significantly <25% can often be attributed to a relative instability of the mutant globin chain, while in some cases high levels may result from coexisting a-thalassemia in the genome, which lowers production of the normal a-globin chains (6) (7) (8) . In a number of situations, however, the factors which contribute to the final level of a-globin mutant are not understood (7) . In order to further investigate such cases, it may be necessary to determine the number and organization of the a-globin genes in the affected individual, as well as the identity and location of the mutant locus. The organization of the a-globin gene cluster can be determined by Southern blot analysis (9) (10) (11) , and the identity of the mutant globin chain can be determined by peptide analysis (2, 3) . However, the location of the mutant locus within the a-globin cluster cannot be determined by either of these methods. The assignment of an a mutation to one of the two a-globin loci would be necessary to establish the exact genotype in each case. We present, in the present report, a technique based upon the divergent structure of the two a-globin mRNAs (12-14) which directly assigns a-globin structural mutations to either the al or the a2 locus. This approach, when combined with presently available protein analytic and gene mapping techniques, should allow a full genetic description of most a-globin structural mutations.
Methods
RNA preparation. Total RNA was isolated from the acid-precipitated polysomes of peripheral reticulocytes as previously described (15 Preparation of plasmids and plasmid paper. All recombinant plasmids were maintained in the EK-2 host bacteria HBI0. They were grown in 1 L batches to an OD6w of 0.8, amplified with chloramphenicol (170 Ag/ml), and harvested 18 h later. Plasmid supercoil was purified from a clarified lysate by cesium chloride isopyknic centrifugation in the presence of 0.75 mg/ml ethidium bromide. To bind plasmids to nitrocellulose paper, 100 ug of plasmid DNA was linearized by restriction endonuclease digestion (pMC18 [17] by EcoRI, pSAR6 [18] by HindIII, pH3alB and pH3a2A by PstI-see Fig. 1 SI nuclease mapping ofa-globin mRNA (19) . To generate 32P endlabeled, single-strand DNA probes for S nuclease mapping, the pRP9 (20) (a2) or pJW1OI (21) (al) cDNA plasmids were digested with HindIII, and the 3' ends were filled in with a32P-dATP using DNA polymerase I (Klenow fragment). The labeled DNA was ethanol precipitated, dissolved in 30% dimethylsulfoxide, I mM EDTA, 0.05% xylene cyanol, 0.05% bromphenol blue, heated to 90°C for 3 min, chilled on ice, and loaded on a 5% strand-separating gel (22 In vitro translation and gel analysis. I Mg of total reticulocyte RNA (total RNA) or 25% of a hybrid-selected mRNA sample was added to a 15 Ml micrococcal nuclease-treated rabbit reticulocyte lysate translation system (23) as previously detailed (24) . Translation was carried out at 270C for 30 min in the presence of 35S-methionine (1,500 Ci/mM, Amersham Corp., Arlington Heights, IL). 5 Ml of each reaction was added to 12 Ml of loading dye (8 M urea, 8% acetic acid, 8% f3-mercaptoethanol, pyronin Y) and applied to a 12.5% acrylamideTriton urea gel (25, 26) . The gel was run, processed, and exposed as previously detailed (15) .
Results
Subcloning the 3'-nontranslated region of the human al-and a2-globin genes. The a 1-and a2-globin mRNAs are identical in primary structure throughout their 5'-nontranslated regions and their entire coding regions. Structural divergence is limited to the 110 nucleotide 3'-nontranslated region, which contains 18 base differences and a single base insertion/deletion (12) (13) (14) . To isolate a fragment of DNA that could hybridize specifically to the a 1 or a2 mRNA, we subcloned the 3'-nontranslated region from both the a 1 and a2 genes. The details of this subcloning are shown in Fig. 1 . The a 1-globin 3'-nontranslated region was isolated from a human a 1 -globin genomic clone (pRBal) (27) on a 143 base pair (bp) BglIPvuII fragment. After filling in its ends, this fragment was gel purified, ligated to the plasmid vector pBR322 between the HindIII and PvuII sites, and transfected into E. coli HB101. Recombinant plasmids were identified by in situ hybridization to a 32P-labeled a-globin cDNA probe and further screened by restriction analysis to identify the expected 143-bp insert. The a2 3'-nontranslated region was subcloned in a similar fashion. A 132 bp Alul/HindIII fragment from the human a2-globin cDNA plasmid pRP9 (20) was gel purified and ligated to the plasmid vector pBR322 between the HindIII and PvuII sites. Colonies were screened and analyzed as described above. The subclone isolated from the 3'-nontranslated region of a 1, pH3alB, and the subclone isolated from the 3'-nontranslated region of a2, pH3a2A, were purified, linearized, and used to construct al and a2 plasmid paper.
Hybrid selection of f, a (total), al, and a2 mRNA. The steps in the hybrid selection are schematicized in Fig. 2 and detailed in Methods. 25-50 gg of reticulocyte RNA was separately hybridized to each of the four plasmid papers. ,B, a, a 1, and a2 plasmid papers contain, respectively, the full length $ cDNA plasmid pSAR6 (18) , the full length a-globin (chimpanzee) cDNA plasmid, pMC 18 (17) , and the two cDNA subclones, pH3a lB and pH3a2A (described above). The described washing and elution conditions routinely yield pure a and , mRNA and a 1 and a2 mRNAs with little or no crosscontamination.
SI nuclease mapping of hybrid-selected a-globin mRNAs. The relative content of al-and a2-globin mRNA in each of the hybrid-selected samples, a, al, and a2, was determined using the previously described Sl nuclease mapping procedure (19 Hybrid selection of normal al-and a2-globin mRNA. The hybrid selection procedure was first used on reticulocyte RNA isolated from an individual who has normal a-globin chains.
1, a, al, and a2 mRNA were hybrid selected. The relative content of a1 and a2 in each a-globin mRNA sample was then determined by SI mapping. The results in lanes 1-4 ( Fig.   4 A) demonstrate the clean separation of al from a2 mRNA.
In the total a-globin mRNA sample (Fig. 4 A, lanes 5 and 6), the S1 mapping demonstrated the previously reported excess of a2 mRNA in normal reticulocytes (19, 28) . Each hybridselected sample was translated in vitro (Fig. 4 B) . Locus identification of a)25'P (Hb Quong Sze) and a7His (Hb Hasharon). Reticulocyte RNA was isolated from the blood of two individuals with known a-globin mutations. The individual with a"25" has been previously described in detail (29 from one chromosome and a nondeletion a-thalassemia defect that destroyed the function of one of the two a-globin genes on the homologous chromosome. This nondeletion defect was defined by functional studies to be the result of an extremely unstable a-globin structural mutant encoded by the nondeletion a-thalassemia gene (15) . This gene was localized to the a2 locus by DNA sequence analysis (30) . To test the ability of the hybrid-selection approach to identify an a-globin mutant locus, we isolated al-and a2-globin mRNA from this individual's reticulocytes and translated them in vitro. S1 analysis showed that a2 is in its normal threefold excess in the unfractionated a-globin mRNA as previously reported (28) (Fig. 5 A, lanes 5 and 6) . The mRNAs in the a and a2 samples were highly purified and showed no evidence of crosscontamination. mRNA from the (3, a, a 1, and a2 samples were translated in vitro (Fig. 5 B) . Translation of the a yielded the normal a-globin, while translation of a2 produced the mutant a-globin ad251pr. Therefore, localization of the mutant to the a2 locus by the method of hybrid-selected translation agreed with the previous assignment by gene isolation and sequence analysis. We next studied an individual with an a-globin structural variant that was not previously localized within the a-globin cluster. The identification of this a-globin as a47His (Hb Has- haron) (31) cyte RNA was fractionated into a, al, and a2 mRNA by hybrid selection. The relative concentration of al and a2 mRNA in each sample (al in lanes 1 and 2; a2 in lanes 3 and 4; a total in lanes 5 and 6) was determined by S1 mapping using an al S1 probe (lanes 2, 4, and 6) or an a2 S1 probe (lanes 1, 3 and 5). (B) In vitro translation of hybrid-selected mRNA. Total reticulocyte RNA and aliquots of a2, al, a, and hybrid-selected mRNA samples were translated and analyzed as in Fig. 4 . The position of normal (3, a, and the a'251"" are noted. The band above a"25Pro is an a-globin oxidation product. The full a-globin genotype of this individual is noted below the gel. globin gene organization (data not shown). The a-globin mRNA was separated into al and a2 samples by hybrid selection, and S1 analysis of these samples demonstrated no appreciable cross-contamination (Fig. 6 A) . In vitro translation of the al sample produced normal a-globin, while the a2 mRNA encoded approximately equal amounts of a and a47His (Fig. 6 B) . This data directly localized the a47His to the a2 locus on one chromosome while demonstrating that the a2 locus on the homologous chromosome encodes a structurally normal protein. This information, combined with the Southern mapping data, can be summarized in a fully defined genotype as shown at the bottom of Fig. 6 B.
Discussion
The present report describes a rapid and definitive method for the localization of a-globin structural mutants to one of the two a-globin loci. This method uses the technique of hybridselected translation (32) (33) (34) , which has previously been used to map structural loci within viral genomes (32) and to confirm the identity of a variety of cDNA clones (33, 34) . A number of factors make hybrid-selected translation particularly useful in the globin systems. mRNA can be isolated from easily obtainable peripheral blood samples. Even in the absence of reticulocytosis, sufficient mRNA for the assay as we describe can be isolated from as little as 50 ml of blood. This is in part due to the fact that reticulocyte mRNA is >90% enriched for globin mRNA (35) . Genomic and cDNA clones encoding each of the globin chains are now available. Specific hybridization to any of the major globin mRNA species can be achieved by isolating regions that will achieve maximal specificity of hybridization to each mRNA species. Finally, based upon several decades of work analyzing the human globin proteins and their variants, numerous techniques are available both to identify specific hemoglobin variants and to separate and characterize the in vitro translation products of the selected globin mRNAs.
In adopting this approach to identify the genetic locus of al-and a2-globin mutations, the primary problem was to isolate their respective al and a2 mRNAs. Previous sequence analysis has shown that the only region of structural divergence between the two a-globin mRNAs is in the 3'-nontranslated region (12) (13) (14) . In this 110 nucleotide region, the two a-globin mRNAs differ by 18 nonhomologous bases and a single base insertion/deletion, which results in a net divergence of 16%. To maximize the usefulness of this region in differential hybridization to the two a-globin mRNA species, the homologous 5'-noncoding and entire coding regions had to be eliminated. The 3'-noncoding regions of al and a2 were therefore separately subcloned, attached to nitrocellulose paper, and the hybridization stringency was adjusted to maximize specific hybridization to their homologous mRNAs.
A difficulty which we have encountered in the general usefulness of this approach occurs in separating mutant from normal globin chain. For instance, in Fig. 4 , the (l-globin gene which is in fact -a mutant (fs) co-migrates with normal 1#I.
Similarly, several a structural mutants that we have studied (GPhi'a [36] , JOxford [37]) do not separate adequately from their normal counterparts on the Triton gel system which we are using. Thus, the labeled globin chain synthesized by in vitro translation of the selected RNAs from these individuals must be analyzed by a different method, such as isoelectric focusing (38) or carboxymethyl cellulose chromatography (39), to identify and characterize the mutation. Since the amount of radioactivity incorporated into the globin chains during in vitro translation is small, these systems must be adapted to appropriate sensitivity.
The ease of obtaining RNA for assay and the definitive nature of this approach will now allow assignment of most aglobin structural mutations to their encoding loci. Over 100 such mutations have been reported (1) . It will be of interest to see if these mutations are equally distributed between the two loci or found preferentially at one or the other. In this regard, it is of interest to note that of the nine a-globin mutations (structural and nondeletion a-thalassemia) which have now been assigned to a particular locus, eight are a2 (Table I) . While this marked asymmetry in a-globin gene mutations may reflect an aberrance of the relatively small sample size, it may alternatively offer a clue to understanding the evolution of the a-globin gene cluster (see below). Assignment of the a structural mutations to their encoding loci will expand the sample size and significantly clarify this issue.
Are the two a-globin genes equally expressed? The aglobin mutants are generally expressed at 20-25% of total a, although a wide spectrum of levels has been documented (1, 5) . The average level of 25% implies that all four a-globin genes are expressed equally at the protein level. Studies which have quantitated the relative concentrations of al and a2 mRNA in normal individuals have, however, documented a 2-3-fold excess of a2 mRNA over a 1 mRNA (19, 28) . In vitro translational studies suggest that al and a2 gene expression may be balanced to produce equal amounts of protein by a higher translation efficiency of the al mRNA (40) . By correlating the level of expression of a-globin mutants with their encoding loci, it may be possible to determine if the two loci are indeed expressed equally in vivo or if the observed expression levels differ according to encoding locus.
Finally, locus assignment of a-globin mutations may shed light on the evolution ofthe a-globin cluster. Extensive sequence (14, 17, (41) (42) (43) . These events are currently referred to as gene conversions (41, (44) (45) (46) and result in concerted evolution (41) of both linked (14, 27, 41, 42, 47) , as well as unlinked, genes (48) . Gene conversion events between the two adjacent a-globin genes appears to occur frequently in primates (17, 41) . If such an event occurred in a genome containing a preexisting a-globin mutation, that mutation might subsequently be found at both a-globin loci on the same chromosome. In such a genotype, the level of aglobin mutant would be expected to approach 50%. Association of such a chromosome with a single or double a-globin deletion on the homologous chromosome (a-Thal-2 or a-Thal-1 chromosome, respectively) would result in a-globin mutant levels of 66 or 100%, respectively. Assuming that the conversion unit does not include the 3'-nontranslated region (43) , the hybrid-assisted translation would detect the mutant protein encoded by both al and a2 mRNAs. Recent studies on an individual with an unusually high (65%) level of the a-globin mutant al6Glu (Hb') have in fact documented the presence of such a chromosome in which both a-globin loci on a single chromosome encode the identical mutation (49) . It is anticipated that in the future other examples of gene conversion may be identified by a-globin locus assignment in individuals with unusually high levels of mutant chains. By establishing the full a-globin genotype in individuals with higher than expected levels of a-globin structural mutations, it may be possible to identify additional evidence of concerted evolution in the human a-globin gene cluster and estimate its frequency and importance.
